scispace - formally typeset
Search or ask a question
Institution

Peking Union Medical College Hospital

HealthcareBeijing, China
About: Peking Union Medical College Hospital is a healthcare organization based out in Beijing, China. It is known for research contribution in the topics: Medicine & Population. The organization has 15996 authors who have published 16018 publications receiving 226505 citations.


Papers
More filters
Journal ArticleDOI
TL;DR: The Surviving Sepsis Campaign Coronavirus Diease 2019 (SCCD) 2019 panel as mentioned in this paper provided guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU.
Abstract: Background The coronavirus disease 2019 pandemic continues to affect millions worldwide. Given the rapidly growing evidence base, we implemented a living guideline model to provide guidance on the management of patients with severe or critical coronavirus disease 2019 in the ICU. Methods The Surviving Sepsis Campaign Coronavirus Disease 2019 panel has expanded to include 43 experts from 14 countries; all panel members completed an electronic conflict-of-interest disclosure form. In this update, the panel addressed nine questions relevant to managing severe or critical coronavirus disease 2019 in the ICU. We used the World Health Organization's definition of severe and critical coronavirus disease 2019. The systematic reviews team searched the literature for relevant evidence, aiming to identify systematic reviews and clinical trials. When appropriate, we performed a random-effects meta-analysis to summarize treatment effects. We assessed the quality of the evidence using the Grading of Recommendations, Assessment, Development, and Evaluation approach, then used the evidence-to-decision framework to generate recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Results The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued nine statements (three new and six updated) related to ICU patients with severe or critical coronavirus disease 2019. For severe or critical coronavirus disease 2019, the panel strongly recommends using systemic corticosteroids and venous thromboprophylaxis but strongly recommends against using hydroxychloroquine. In addition, the panel suggests using dexamethasone (compared with other corticosteroids) and suggests against using convalescent plasma and therapeutic anticoagulation outside clinical trials. The Surviving Sepsis Campaign Coronavirus Diease 2019 panel suggests using remdesivir in nonventilated patients with severe coronavirus disease 2019 and suggests against starting remdesivir in patients with critical coronavirus disease 2019 outside clinical trials. Because of insufficient evidence, the panel did not issue a recommendation on the use of awake prone positioning. Conclusion The Surviving Sepsis Campaign Coronavirus Diease 2019 panel issued several recommendations to guide healthcare professionals caring for adults with critical or severe coronavirus disease 2019 in the ICU. Based on a living guideline model the recommendations will be updated as new evidence becomes available.

257 citations

Journal ArticleDOI
TL;DR: 2 large, multicenter randomized clinical trials evaluating the safety and efficacy of anti-VEGF monotherapy and combination with photodynamic therapy (PDT) recently reported initial first-year outcomes, providing level I evidence to guide clinicians in choosing the most appropriate therapy for PCV.

250 citations

Journal ArticleDOI
TL;DR: This database is expected to be a valuable source for identification of cancer-related miRNAs, thereby helping with the improvement of classification, diagnosis and treatment of human cancers.
Abstract: Background MicroRNAs (miRNAs) are small noncoding RNAs about 22 nt long that negatively regulate gene expression at the post-transcriptional level. Their key effects on various biological processes, e.g., embryonic development, cell division, differentiation and apoptosis, are widely recognized. Evidence suggests that aberrant expression of miRNAs may contribute to many types of human diseases, including cancer. Here we present a database of differentially expressed miRNAs in human cancers (dbDEMC), to explore aberrantly expressed miRNAs among different cancers.

249 citations

Journal ArticleDOI
TL;DR: The causative organism was identified on 7 January 2020 as a novel coronavirus (nCOV) and the genetic sequence of at least 19 strains found in infected patients has been published so far.
Abstract: On 31 December 2019, China notified WHO of a pneumonia outbreak of then unknown aetiology in Wuhan,1 a city of 11 million people in Hubei province. The seafood market which was thought to be the source was closed on 1 January 2020.2 The causative organism was identified on 7 January 2020 as a novel coronavirus (nCOV). The genetic sequence of at least 19 strains found in infected patients has been published so far.3 4 To date, COVID-19 has already confirmed to have affected almost >68,000 with >1600 deaths in China, and over 680 cases outside of China spanning 25 countries over South East Asia, Europe, North America, Australia and the Middle East, etc. This number is expected to rise over the next few months worldwide. So far, 41 million from China and at least 14 cities in the Hubei province have travel restrictions, some with suspension of outbound flights and trains as well as other public transport, and many countries are taking measures to quarantine travellers from China. Comparisons are being made with severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), also both caused by coronaviruses. SARS emerged in 2003 and caused the first pandemic of the 21st century, affecting more than 8000 people, …

249 citations

Journal ArticleDOI
TL;DR: It is shown that MSCs secreted 40–100 nm particles, which have the typical characteristics of exosomes, and these MSC-derived exosome promoted migration of the breast cancer cell line MCF7.
Abstract: Human mesenchymal stem cell (MSC)-conditioned medium (CM) was previously reported to affect the biology of tumor cells; however, the precise mechanisms remain unclear. Here, we show that MSCs secreted 40–100 nm particles, which have the typical characteristics of exosomes, and these MSC-derived exosomes promoted migration of the breast cancer cell line MCF7. Global gene expression profiling revealed that several cancer-related signaling pathways were upregulated after exosome treatment in MCF7, and the Wnt signaling pathway was further confirmed to be activated. Our findings demonstrated a new mechanism through which MSC-CM may contribute to tumor cell migration.

246 citations


Authors

Showing all 16286 results

NameH-indexPapersCitations
Feng Zhang1721278181865
Jian Li133286387131
Shuai Liu129109580823
Jun Yu121117481186
Edward M. Brown11148944630
Qian Wang108214865557
Ming Li103166962672
Tao Li102248360947
Masatoshi Kudo100132453482
Christophe Tzourio9847553680
Yang Xin Fu9739033526
Michael Q. Zhang9337842008
Xiang Gao92135942047
Jun Li9033961485
Honglei Chen8020783906
Network Information
Related Institutions (5)
Nanjing Medical University
37.9K papers, 635.8K citations

95% related

Capital Medical University
47.2K papers, 811.2K citations

94% related

Peking Union Medical College
61.8K papers, 1.1M citations

93% related

Second Military Medical University
20.4K papers, 449.4K citations

92% related

Oslo University Hospital
23.7K papers, 709.6K citations

88% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202391
2022407
20212,379
20202,395
20191,679
20181,283